Tina Yu, CEO of Mevion Medical Systems, joins The Cancer Project to discuss the company’s breakthrough S250 FIT system, a compact proton therapy solution that fits inside a standard linear accelerator vault, and her vision for making precision cancer treatment accessible to patients worldwide.
Dr. John Chang, Medical Director of the Oklahoma Proton Center, reviews a pivotal phase 3 randomized trial showing proton radiation therapy significantly reduces side effects, and improves five-year overall survival by 10 percentage points, compared to traditional radiation for oropharyngeal cancers.
Return guest Britney Haynes joins the podcast to explore the cancer journeys of famous figures, from Steve Jobs to Princess Kate to Joe Biden, uncovering lessons about early detection, proton therapy, alternative treatments, and the emotional reality of survivorship.
An inside look at the Oklahoma Proton Center, one of the first private proton therapy facilities in the U.S., exploring how proton beam precision reduces radiation to healthy tissue, what the science of ‘know your gray’ means for patients, and why quality of life is as central to treatment as the cure itself.
Jillian Plochocki, Executive Director of the Proton Collaborative Group, joins the podcast to explain how the world’s largest proton therapy registry collects real-world outcomes data from over 40,000 patients, and why that research is transforming cancer treatment standards.
Host David and returning guest Britney Haynes reflect on the passing of James Van Der Beek from stage three colorectal cancer at 46, exploring the alarming rise of colorectal cancer in younger adults, the importance of early screening, and what his story reveals about a disease that doesn’t discriminate by health status.
Medical physicist Niek Schreuder shares five decades of proton therapy innovation, from building South Africa’s first beam line by hand to co-founding Procure Treatment Centers and envisioning the next generation of compact, specialized proton systems.
Britney Haynes and Brandon Jackson examine Walter White’s Stage 3A lung cancer diagnosis in Breaking Bad, exploring the real oncology, financial toxicity, and moral desperation behind one of television’s most iconic storylines.
Dr. Shannon MacDonald joins the podcast to discuss the RADCOMP trial, the largest randomized study comparing proton and photon radiation therapy for locally advanced breast cancer, including preliminary findings on patient-reported outcomes and what the data means for patients making radiation treatment decisions.
Mark Malin, US President of RaySearch Americas, breaks down the science of treatment planning, from the 3D “digital twin” of the patient, to organs at risk, online adaptive therapy, and how AI will transform radiation oncology.
